These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8692788)

  • 21. Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer?
    Vellas B; Andrieu S; Cantet C; Dartigues JF; Gauthier S
    J Nutr Health Aging; 2007; 11(4):338-41. PubMed ID: 17653494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Touch Panel-type Dementia Assessment Scale: a new computer-based rating scale for Alzheimer's disease.
    Inoue M; Jimbo D; Taniguchi M; Urakami K
    Psychogeriatrics; 2011 Mar; 11(1):28-33. PubMed ID: 21447106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of higher-dose 13.3 mg/24 h (15 cm2) rivastigmine patch on the Alzheimer's Disease Assessment Scale-cognitive subscale: domain and individual item analysis.
    Alva G; Isaacson R; Sadowsky C; Grossberg G; Meng X; Somogyi M
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):920-7. PubMed ID: 24549933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles.
    Le Bars PL
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S50-5. PubMed ID: 13130389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
    Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
    Alzheimers Dement; 2009 Sep; 5(5):375-9. PubMed ID: 19751916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological testing and assessment scales for dementia of the Alzheimer's type.
    Morgan CD; Baade LE
    Psychiatr Clin North Am; 1997 Mar; 20(1):25-43. PubMed ID: 9139294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular Factors and Cognitive Dysfunction in Alzheimer Disease.
    Pąchalska M; Bidzan L; Bidzan M; Góral-Półrola J
    Med Sci Monit; 2015 Nov; 21():3483-9. PubMed ID: 26561951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of Alzheimer disease assessment scale-cognitive part in predicting progress for amnestic mild cognitive impairment to Alzheimer disease.
    Rozzini L; Vicini Chilovi B; Bertoletti E; Conti M; Delrio I; Trabucchi M; Padovani A
    J Geriatr Psychiatry Neurol; 2008 Dec; 21(4):261-7. PubMed ID: 19017783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revising the ADAS-cog for a more accurate assessment of cognitive impairment.
    Wouters H; van Gool WA; Schmand B; Lindeboom R
    Alzheimer Dis Assoc Disord; 2008; 22(3):236-44. PubMed ID: 18580585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The TE4D-Cog: a new test for detecting early dementia in English-speaking populations.
    Mahoney R; Johnston K; Katona C; Maxmin K; Livingston G
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1172-9. PubMed ID: 16315149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Executive function impairment in community elderly subjects with questionable dementia.
    Lam LC; Lui VW; Chiu HF; Chan SS; Tam CW
    Dement Geriatr Cogn Disord; 2005; 19(2-3):86-90. PubMed ID: 15572877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-national comparison and validation of the Alzheimer's Disease Assessment Scale: results from the European Harmonization Project for Instruments in Dementia (EURO-HARPID).
    Verhey FR; Houx P; Van Lang N; Huppert F; Stoppe G; Saerens J; Böhm P; De Vreese L; Nordlund A; DeDeyn PP; Neri M; Peña-Casanova J; Wallin A; Bollen E; Middelkoop H; Nargeot MC; Puel M; Fleischmann UM; Jolles J
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):41-50. PubMed ID: 14716698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New scoring methodology improves the sensitivity of the Alzheimer's Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials.
    Verma N; Beretvas SN; Pascual B; Masdeu JC; Markey MK;
    Alzheimers Res Ther; 2015 Nov; 7(1):64. PubMed ID: 26560146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. French-English cross-linguistic comparison and diagnostic impact of the AD-8 dementia screening questionnaire in a geriatric assessment clinic.
    Koski L; Xie H; Konsztowicz S; Tetteh R
    Dement Geriatr Cogn Disord; 2010; 29(3):265-74. PubMed ID: 20375508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease.
    Sultzer DL; Levin HS; Mahler ME; High WM; Cummings JL
    Am J Psychiatry; 1993 Dec; 150(12):1806-12. PubMed ID: 8238634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.
    Stern RG; Mohs RC; Davidson M; Schmeidler J; Silverman J; Kramer-Ginsberg E; Searcey T; Bierer L; Davis KL
    Am J Psychiatry; 1994 Mar; 151(3):390-6. PubMed ID: 8109647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.